Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer.

MLA

Bramante, Simona, et al. “Oncolytic Virotherapy for Treatment of Breast Cancer, Including Triple-Negative Breast Cancer.” OncoImmunology, vol. 5, no. 2, Feb. 2016, p. 1. EBSCOhost, https://doi.org/10.1080/2162402X.2015.1078057.

APA

Bramante, S., Koski, A., Liikanen, I., Vassilev, L., Oksanen, M., Siurala, M., Heiskanen, R., Hakonen, T., Joensuu, T., Kanerva, A., Pesonen, S., & Hemminki, A. (2016). Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer. OncoImmunology, 5(2), 1. https://doi.org/10.1080/2162402X.2015.1078057

Chicago

Bramante, Simona, Anniina Koski, Ilkka Liikanen, Lotta Vassilev, Minna Oksanen, Mikko Siurala, Raita Heiskanen, et al. 2016. “Oncolytic Virotherapy for Treatment of Breast Cancer, Including Triple-Negative Breast Cancer.” OncoImmunology 5 (2): 1. doi:10.1080/2162402X.2015.1078057.